# GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

> **NCT07633639** · NA · RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Obesity

## Interventions

- **COMBINATION_PRODUCT:** LSG-Semaglutide group
- **COMBINATION_PRODUCT:** LSG-Mazdutide group
- **COMBINATION_PRODUCT:** LSG-Tirzepatide group
- **PROCEDURE:** LSG group

## Key facts

- **NCT ID:** NCT07633639
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633639, "GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07633639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*